Two TROP2 Conjugates Reached the Same Patients Ten Weeks Apart, and Payers Finally Have a Choice to Make
Until this summer every approved ADC held its indication alone. Two TROP2 conjugates now share one first-line population, and payers finally have a comparator.
DealPulse Signal
The Beats
Analysis
The Briefs
Two TROP2 Conjugates Reached the Same Patients Ten Weeks Apart, and Payers Finally Have a Choice to Make
CMS Projects: Fewer Losses and Bigger Savings. That Only Works If the Sick Are Removed.
Two Dominican High-Cost Lists Overlap by Only 44 Products. FOMAC Would Be a Third.
The Effect Size Is 0.81. The Number That Decides the Business Is 6.4 Hours.
Lilly Can Sue the Sellers. It Can Only Ask the Payment Networks.